14 articles for TG Davies
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery.

Astex Pharmaceuticals
Identification of 4-(4-aminopiperidin-1-yl)-7H-pyrrolo[2,3-d]pyrimidines as selective inhibitors of protein kinase B through fragment elaboration.

The Institute of Cancer Research
Discovery of 4-amino-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamides as selective, orally active inhibitors of protein kinase B (Akt).

The Institute of Cancer Research
Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2).

Astex Pharmaceuticals
Fragment-Guided Discovery of Pyrazole Carboxylic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2 Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction.

Astex Pharmaceuticals
Structure-Activity and Structure-Conformation Relationships of Aryl Propionic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1/Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1/NRF2) Protein-Protein Interaction.

Astex Pharmaceuticals
Treatment of dry eye

Principia Biopharma
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

Theravance Respiratory
Substituted 2-aminopyridine protein kinase inhibitor

Chia Tai Tianqing Pharmaceutical Group
Heterocyclic compounds and methods for their use

Novartis
4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof

Bayer Intellectual Property
Synthesis and SAR of potent EGFR/erbB2 dual inhibitors.

Glaxosmithkline
Synthesis and initial SAR studies of 3,6-disubstituted pyrazolo[1,5-a]pyrimidines: a new class of KDR kinase inhibitors.

Merck Research Laboratories